nad has been researched along with HbS Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cimpeanu, E; Dutta, D; Jafri, F; Jang, T; Lim, SH; Poplawska, M; Seong, G | 1 |
| Cox, SE; Hart, E; Kirkham, FJ; Stotesbury, H | 1 |
| Ortiz de Montellano, PR | 1 |
| Al-Ali, AK | 1 |
| SEVER, JL | 1 |
| BAXI, AJ; BHATIA, HM; NAIK, PV; NAIK, SN | 1 |
| Akiyama, DS; Niihara, Y; Tanaka, KR; Zerez, CR | 2 |
| Hebbel, RP; Repka, T | 1 |
| Lachant, NA; Tanaka, KR; Zerez, CR | 2 |
| Lachant, NA; Lee, SJ; Tanaka, KR; Zerez, CR | 1 |
| Ben-Bassat, I; Beutler, E; Paniker, NV | 1 |
| Itie, R; Orsini, A; Perrimond, H; Vovan, L | 1 |
1 review(s) available for nad and HbS Disease
| Article | Year |
|---|---|
L-glutamine for sickle cell disease: more than reducing redox.
Topics: Anemia, Sickle Cell; Glutamine; Hemoglobinopathies; Humans; NAD; Oxidation-Reduction; Volatile Organic Compounds | 2022 |
1 trial(s) available for nad and HbS Disease
| Article | Year |
|---|---|
Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential.
Topics: Administration, Oral; Adult; Anemia, Sickle Cell; Dietary Supplements; Erythrocytes; Glutamine; Humans; Middle Aged; NAD; Oxidation-Reduction; Pilot Projects; Treatment Outcome | 1998 |
12 other study(ies) available for nad and HbS Disease
| Article | Year |
|---|---|
L-Glutamine in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Animals; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Erythrocytes; Glutamine; Humans; Mice; NAD; Randomized Controlled Trials as Topic | 2020 |
A New Step in the Treatment of Sickle Cell Disease
Topics: Amide Synthases; Ammonia; Anemia, Sickle Cell; Animals; Antisickling Agents; Drug Discovery; Glutaminase; Glutamine; Humans; NAD | 2018 |
Pyridine nucleotide redox potential in erythrocytes of saudi subjects with sickle cell disease.
Topics: Anemia, Sickle Cell; Arabs; Black or African American; Black People; Erythrocyte Count; Erythrocytes, Abnormal; Female; Fetal Hemoglobin; Glycolysis; Humans; Male; NAD; NADP; Oxidation-Reduction; Saudi Arabia; United States | 2002 |
Diphosphopyridine nucleotide binding effect of sickle cell erythrocytes on in vitro growth of Hemophilus influenzae.
Topics: Anemia; Anemia, Sickle Cell; Coenzymes; Erythrocytes, Abnormal; Haemophilus influenzae; Humans; In Vitro Techniques; NAD | 1961 |
HEMATOLOGICAL STUDY OF INDIAN SPOTTED DEER (AXIS DEER).
Topics: Anemia; Anemia, Sickle Cell; Animals; Antigens; Artiodactyla; Blood Protein Electrophoresis; Electron Spin Resonance Spectroscopy; Erythrocyte Count; Erythrocytes; Glucosephosphate Dehydrogenase; Hemoglobins; Humans; Immune Sera; NAD; Research | 1964 |
Increased red cell glutamine availability in sickle cell anemia: demonstration of increased active transport, affinity, and increased glutamate level in intact red cells.
Topics: Anemia, Sickle Cell; Biological Transport, Active; Erythrocytes; Glutamic Acid; Glutamine; Humans; Kinetics; NAD | 1997 |
Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents.
Topics: Anemia, Sickle Cell; Ascorbic Acid; Deferoxamine; Erythrocyte Membrane; Free Radicals; Glutathione; Heme; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Iron; Kinetics; Lipid Peroxidation; NAD; NADP; Oxidation-Reduction; Reference Values | 1991 |
Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content.
Topics: Anemia, Sickle Cell; Cytochrome-B(5) Reductase; Erythrocytes; Hemoglobin, Sickle; Hexokinase; Humans; Kinetics; Methemoglobin; NAD; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Reference Values; Thalassemia | 1990 |
Relationship between the nicotinamide adenine dinucleotide redox potential and the 2,3-diphosphoglycerate content in the erythrocyte in sickle cell disease.
Topics: 2,3-Diphosphoglycerate; Anemia, Hemolytic, Autoimmune; Anemia, Sickle Cell; Diphosphoglyceric Acids; Erythrocytes; Erythrocytes, Abnormal; Hematocrit; Humans; NAD; Oxidation-Reduction | 1989 |
Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.
Topics: Anemia, Sickle Cell; Erythrocytes; Humans; NAD; NADP; Oxidation-Reduction | 1988 |
Evaluation of sickle hemoglobin and desickling agents by falling ball viscometry.
Topics: 6-Phytase; Anemia, Sickle Cell; Aspirin; Blood Viscosity; Carbamates; Cyanates; Drug Storage; Fructose; Glyceraldehyde; Glyceric Acids; Hemoglobins, Abnormal; Humans; Inositol; Methemoglobin; NAD; Phosphoric Acids; Potassium; Pyridoxal Phosphate; Time Factors; Urea; Valine; Vinblastine | 1972 |
[Free nucleotides of erythrocytes in anemias in children. Results of 64 examinations].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Anemia, Sickle Cell; Child; Chromatography, Ion Exchange; Elliptocytosis, Hereditary; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; Hemoglobin C; Hemoglobin C Disease; Hemoglobinopathies; Humans; Hypersplenism; Methods; NAD; NADP; Spectrophotometry; Spherocytosis, Hereditary; Thalassemia | 1969 |